Evidence map›Paper›PMID 26354441›Full record

ArticleThe Journal of biological chemistry2015

Structure and function of the Escherichia coli Tol-Pal stator protein TolR.

Justyna A Wojdyla, Erin Cutts, Renata Kaminska, Grigorios Papadakos, Jonathan T S Hopper, Phillip J Stansfeld, David Staunton, Carol V Robinson, Colin Kleanthous

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Advances in understanding Ton and Tol system motor proteins.Biochemical Society transactions · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Review
  10. Article
  11. Development of aFrontiers in microbiology · 2024
    Article
  12. Article
  13. Article
  14. Tunable force transduction through theProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Justyna A WojdylaFrom the Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU and.
Erin CuttsFrom the Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU and.
Renata KaminskaFrom the Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU and.
Grigorios PapadakosFrom the Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU and.
Jonathan T S Hopperthe Department of Chemistry, University of Oxford, Mansfield Road, Oxford OX1 3TA, United Kingdom.
Phillip J StansfeldFrom the Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU and.
David StauntonFrom the Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU and.
Carol V Robinsonthe Department of Chemistry, University of Oxford, Mansfield Road, Oxford OX1 3TA, United Kingdom.
Colin KleanthousFrom the Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU and colin.kleanthous@bioch.ox.ac.uk.
University of Oxford · GB

Funding

Biotechnology and Biological Sciences Research Council BB/G020671/1
6 · The paper itself

Abstract

TolR is a 15-kDa inner membrane protein subunit of the Tol-Pal complex in Gram-negative bacteria, and its function is poorly understood. Tol-Pal is recruited to cell division sites where it is involved in maintaining the integrity of the outer membrane. TolR is related to MotB, the peptidoglycan (PG)-binding stator protein from the flagellum, suggesting it might serve a similar role in Tol-Pal. The only structure thus far reported for TolR is of the periplasmic domain from Haemophilus influenzae in which N- and C-terminal residues had been deleted (TolR(62-133), Escherichia coli numbering). H. influenzae TolR(62-133) is a symmetrical dimer with a large deep cleft at the dimer interface. Here, we present the 1.7-Å crystal structure of the intact periplasmic domain of E. coli TolR (TolR(36-142)). E. coli TolR(36-142) is also dimeric, but the architecture of the dimer is radically different from that of TolR(62-133) due to the intertwining of its N and C termini. TolR monomers are rotated ∼180° relative to each other as a result of this strand swapping, obliterating the putative PG-binding groove seen in TolR(62-133). We found that removal of the strand-swapped regions (TolR(60-133)) exposes cryptic PG binding activity that is absent in the full-length domain. We conclude that to function as a stator in the Tol-Pal complex dimeric TolR must undergo large scale structural remodeling reminiscent of that proposed for MotB, where the N- and C-terminal sequences unfold in order for the protein to both reach and bind the PG layer ∼90 Å away from the inner membrane.

Indexed as

Amino Acid SequenceBacterial Outer Membrane ProteinsBacterial ProteinsBinding SitesCrystallography, X-RayEscherichia coliEscherichia coli ProteinsFlagellaGene ExpressionHydrophobic and Hydrophilic InteractionsLipoproteinsMembrane ProteinsModels, MolecularMolecular Sequence DataPeptidoglycanPeriplasmBacterial Outer Membrane ProteinsBacterial ProteinsEscherichia coli ProteinsExcC protein, E coliLipoproteinsMembrane ProteinsMotB protein, BacteriaPeptidoglycanRecombinant ProteinstolR protein, E colibacteriacrystal structuredimerizationdomainEscherichia coli (E. coli)membrane proteinperiplasmstrand-swappedTolR

Identifiers

PMID26354441
PMCPMC4646322
OpenAlexW1848460403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.